Market Indices
Sector Heatmap
ALKS — Alkermes Inc. plc
NasdaqAlkermes Inc. plc
- O
- 40.00
- H
- 41.41
- L
- 39.99
- V
- 2.28M
ALKS — Latest News & Headlines
19 StoriesAlkermes plc (ALKS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alkermes plc (ALKS) Stock Price, News, Quote & History Yahoo! Finance Canada
Alkermes (ALKS) Stock Looks Rich As Fresh ADHD Trial News Lands - Simply Wall Street
Alkermes (ALKS) Stock Looks Rich As Fresh ADHD Trial News Lands Simply Wall Street
Alkermes Falls as Investors Appear to Take Profits Despite No Obvious Negative Company Update - Quiver Quantitative
Alkermes Falls as Investors Appear to Take Profits Despite No Obvious Negative Company Update Quiver Quantitative
An ADHD drug in testing cut symptom scores by 19 points - Stock Titan
An ADHD drug in testing cut symptom scores by 19 points Stock Titan
What This Biotech Learned From Narcolepsy And Took To ADHD - Investor's Business Daily
What This Biotech Learned From Narcolepsy And Took To ADHD Investor's Business Daily
LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now? - The Globe and Mail
LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now? The Globe and Mail
Alkermes rises on phase 1 results for ADHD drug ALKS 7290 - Seeking Alpha
Alkermes rises on phase 1 results for ADHD drug ALKS 7290 Seeking Alpha
Technical Reactions to ALKS Trends in Macro Strategies - Stock Traders Daily
Technical Reactions to ALKS Trends in Macro Strategies Stock Traders Daily
What ALKS 7290 ADHD Trial Results Mean For Alkermes (ALKS) Stock - Simply Wall Street
What ALKS 7290 ADHD Trial Results Mean For Alkermes (ALKS) Stock Simply Wall Street
Goldman Sachs resumes Alkermes stock coverage with neutral rating - Investing.com
Goldman Sachs resumes Alkermes stock coverage with neutral rating Investing.com
Alkermes: Idiopathic Hypersomnia Could Expand LUMRYZ Into A Larger Growth, Margin Driver - Seeking Alpha
Alkermes: Idiopathic Hypersomnia Could Expand LUMRYZ Into A Larger Growth, Margin Driver Seeking Alpha
ALKS Oct 2026 46.000 call (ALKS261016C00046000) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALKS Oct 2026 46.000 call (ALKS261016C00046000) Stock Price, News, Quote & History Yahoo! Finance Canada
Will Phase 1 ADHD Data Change Alkermes Stock Narrative - Simply Wall Street
Will Phase 1 ADHD Data Change Alkermes Stock Narrative Simply Wall Street
Alkermes (ALKS), What Is Behind The Fresh Attention? - Simply Wall Street
Alkermes (ALKS), What Is Behind The Fresh Attention? Simply Wall Street
ALKS Oct 2026 55.000 call (ALKS261016C00055000) stock price, news, quote and history - Yahoo Finance UK
ALKS Oct 2026 55.000 call (ALKS261016C00055000) stock price, news, quote and history Yahoo Finance UK
ALKS Oct 2026 42.000 put (ALKS261016P00042000) stock price, news, quote and history - Yahoo Finance Singapore
ALKS Oct 2026 42.000 put (ALKS261016P00042000) stock price, news, quote and history Yahoo Finance Singapore
ALKS Earnings Overview 2026-09-19 - Guidance Revision Trend - dars.gov.et
ALKS Earnings Overview 2026-09-19 - Guidance Revision Trend dars.gov.et
Alkermes Stock Slumps Despite Optimistic ADHD Pipeline Buzz - TipRanks
Alkermes Stock Slumps Despite Optimistic ADHD Pipeline Buzz TipRanks
Alkermes Drops As ADHD Trial Hype Fizzles - TipRanks
Alkermes Drops As ADHD Trial Hype Fizzles TipRanks